Cargando…
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary
BACKGROUND: Dexmedetomidine is currently off-label for use in pediatric clinical care worldwide. Nevertheless, it is frequently prescribed to pediatric patients as premedication prior to induction of anesthesia or for procedural sedation. There is ample literature on the pharmacokinetics, efficacy a...
Autores principales: | Freriksen, Jolien J. M., van der Zanden, Tjitske M., Holsappel, Inge G. A., Molenbuur, Bouwe, de Wildt, Saskia N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068679/ https://www.ncbi.nlm.nih.gov/pubmed/35344192 http://dx.doi.org/10.1007/s40272-022-00498-y |
Ejemplares similares
-
Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy
por: van der Zanden, Tjitske M., et al.
Publicado: (2022) -
Intranasal Fentanyl, Midazolam and Dexmedetomidine as Premedication in Pediatric Patients
por: Chatrath, Veena, et al.
Publicado: (2018) -
Alternative sedation premedication with intranasal dexmedetomidine before dental procedures
por: Po-Heng, Chen, et al.
Publicado: (2019) -
Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study
por: Uusalo, Panu, et al.
Publicado: (2019) -
Neonatal Drug Formularies—A Global Scope
por: Shaniv, Dotan, et al.
Publicado: (2023)